Image via Wikipedia
Italian researchers have discovered new stem cells that could be potential sources of ‘spare’ neurons. A study carried out at the University of Verona has led to the discovery of Leptomeningeal Stem Cells (LeSC), a new population of stem cells located in the the meninges, which cover the entire central nervous system in mammals.
LeSCs are immature cells able to maintain themselves and differentiate into mature excitable neurons. This demonstrates that the brain has a greater regenerative capacity than what was believed until now. The results of the study, conducted on an animal model, were
Heart Attack Victim Recovers In Stem Cell Research Study
As part of a new stem cell treatment series, I am trying to find patients who have been helped by Adult Stem Cell research and therapy. In May, I featured a Multiple Sclerosis patient named Arndt Roehlig who described his successful stem cell experience in Israel in […]
An ‘antenna’ molecule, which is capable of guiding blood stem cells to their natural ‘home’, the bone marrow, has been discovered. The discovery could improve the efficiency of umbilical cord stem cell transplants. This type of transplant is not efficient when there are not many umbilical cord stem cells present, since few of them are able to reach the bone marrow from the blood.
Reported by Nature magazine, the discovery was made by David Scadden of the Harvard Stem Cell Institute in Boston. The stem cells, which normally renew the population of blood cells in the body
“Now that we have identified SOX10 as an initiator of myelination, we can work on developing a viral or pharmaceutical approach to inducing it in MS patients,” says Fraser J. Sim, PhD, assistant professor and senior author of the paper.
Transcription factors are proteins or molecules that bind to DNA and alter which genes are turned on, or expressed.
“If we could create a drug that would switch on SOX10, that would be therapeutically important,” Sim explains.
Removing Barriers to MS Stem Cell Therapy
Targeting SOX10 offers hope for a viable stem cell treatment for MS.
Long seen as having dramatic potential for treating
A biopolymer could aid in the regrowing of nerves induced by the use of stem cells according to a new research project that gives hope to people who have been in an accident and have lost the use of one or more limbs. The procedure will enter into clinical testing in January after animal testing has been completed.
The Experimental Neurological Institute (INSPE), founded in 2005 at San Raffaele Hospital of Milan became operational with the inauguration of more than 1,200 square meters of lab space entirely dedicated to general and clinical research therapies for serious neurological diseases,